Notice2021-28032
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 27, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 245 (Monday, December 27, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Pages 73286-73287]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-28032]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0852]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Prevalence Survey of Healthcare-Associated
Infections and Antimicrobial Use in U.S. Acute Care Hospitals to the
Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on August 13, 2021 to obtain
comments from the public and affected agencies. CDC received one non-
substantive comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 10/31/2022)--Extension--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and improving
antimicrobial use (AU) are CDC and national priorities. An essential
step in reducing the occurrence of HAIs is to accurately estimate the
burden of these infections in U.S. acute care hospitals and to describe
the types of HAIs and causative pathogens. Periodic assessments of the
magnitude and types of HAIs and AU occurring in all patient populations
within acute care hospitals are needed to inform decisions by policy
makers and hospital infection control personnel (ICP) regarding
appropriate targets and strategies for HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four prevalence surveys (i.e., pilot
survey in 2009, limited-scale survey in 2010, and two full-scale
surveys in 2011 and 2015) in partnership with the CDC's Emerging
Infections Program (EIP) sites. Findings from the most recent survey
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011. We granted approval from OMB
to conduct the fifth survey in 2020, but due to the COVID-19 pandemic
the survey was postponed to 2023.
Minor adjustments to data collection instruments since the previous
2019 OMB approval have been made. These adjustments were made to
enhance future analyses and utility of the survey data. These changes
are non-substantive and are not expected to increase the public
reporting burden. An extension of the prevalence survey's existing OMB
approval is sought to allow a repeat HAI and AU Prevalence Survey to be
performed in 2023. A repeat survey will allow assessment of changes in
HAI and AU prevalence, pathogen distribution, and quality of
antimicrobial prescribing. These data will also allow CDC and its
partners to continue to monitor HAI and AU trends, to measure progress
in meeting national targets, and to further refine prevention
strategies.
In the 2023 survey, data collection will occur within acute care
general hospitals of varying size in each of the 10 EIP sites (i.e.,
CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN). Infection Control Personnel
in participating hospitals may assist EIP site personnel in collecting
demographic and limited clinical data from the electronic or paper-
based medical records of a sample of randomly selected patients on a
single day in 2023. Patients will not be interviewed, and no direct
interaction with patients will occur. Hospital and patient-level data
will be collected using unique identification codes. EIP site personnel
will submit hospital and patient-level data to CDC using a secure data
management system.
Based on experiences from previous surveys, the time required to
complete the Healthcare Facility Assessment Form (HFA) and Patient
Information Form (PIF) is estimated to be 45 and 17 minutes,
respectively. To conduct the full-scale survey in a three-year approval
period, 100 hospital respondents will complete the HFA once, and the
PIF on average 63 times per year. The total estimated annualized public
burden is 1,860 hours, which represents no change from the 2019 OMB
approval.
To assess changes in HAIs and AU over time, EIP sites will seek
participation from the same hospitals that participated in prior
surveys. These hospitals were originally selected for participation
using a stratified random
[[Page 73287]]
sampling scheme based on the number of staffed acute care beds (i.e.,
small: <150 staffed beds; medium: 151-399 staffed beds; large: >400
staffed beds). Each site will also have the option to recruit
additional hospitals for a total of up to 30 in each site. As in
previous surveys, hospital participation will remain voluntary. Within
each participating hospital, EIP site personnel will establish patient
sample size targets based on the number of staffed acute care beds
(e.g., up to 75 patients in small hospitals, 75 patients in medium
hospitals, and 100 patients in large hospitals).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (Infection HFA..................... 100 1 45/60
Preventionist).
PIF..................... 100 63 17/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-28032 Filed 12-23-21; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on December 27, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.